These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35783256)

  • 1. The Great Majority of Homologous Recombination Repair-Deficient Tumors Are Accounted for by Established Causes.
    Štancl P; Hamel N; Sigel KM; Foulkes WD; Karlić R; Polak P
    Front Genet; 2022; 13():852159. PubMed ID: 35783256
    [No Abstract]   [Full Text] [Related]  

  • 2. Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma.
    Golan T; O'Kane GM; Denroche RE; Raitses-Gurevich M; Grant RC; Holter S; Wang Y; Zhang A; Jang GH; Stossel C; Atias D; Halperin S; Berger R; Glick Y; Park JP; Cuggia A; Williamson L; Wong HL; Schaeffer DF; Renouf DJ; Borgida A; Dodd A; Wilson JM; Fischer SE; Notta F; Knox JJ; Zogopoulos G; Gallinger S
    Gastroenterology; 2021 May; 160(6):2119-2132.e9. PubMed ID: 33524400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Assessment of Diagnostic Homologous Recombination Deficiency-Associated Mutational Signatures in Ovarian Cancer.
    Sztupinszki Z; Diossy M; Borcsok J; Prosz A; Cornelius N; Kjeldsen MK; Mirza MR; Szallasi Z
    Clin Cancer Res; 2021 Oct; 27(20):5681-5687. PubMed ID: 34380641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes.
    Timms KM; Abkevich V; Hughes E; Neff C; Reid J; Morris B; Kalva S; Potter J; Tran TV; Chen J; Iliev D; Sangale Z; Tikishvili E; Perry M; Zharkikh A; Gutin A; Lanchbury JS
    Breast Cancer Res; 2014 Dec; 16(6):475. PubMed ID: 25475740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study.
    Staaf J; Glodzik D; Bosch A; Vallon-Christersson J; Reuterswärd C; Häkkinen J; Degasperi A; Amarante TD; Saal LH; Hegardt C; Stobart H; Ehinger A; Larsson C; Rydén L; Loman N; Malmberg M; Kvist A; Ehrencrona H; Davies HR; Borg Å; Nik-Zainal S
    Nat Med; 2019 Oct; 25(10):1526-1533. PubMed ID: 31570822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer.
    Zhao EY; Shen Y; Pleasance E; Kasaian K; Leelakumari S; Jones M; Bose P; Ch'ng C; Reisle C; Eirew P; Corbett R; Mungall KL; Thiessen N; Ma Y; Schein JE; Mungall AJ; Zhao Y; Moore RA; Den Brok W; Wilson S; Villa D; Shenkier T; Lohrisch C; Chia S; Yip S; Gelmon K; Lim H; Renouf D; Sun S; Schrader KA; Young S; Bosdet I; Karsan A; Laskin J; Marra MA; Jones SJM
    Clin Cancer Res; 2017 Dec; 23(24):7521-7530. PubMed ID: 29246904
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder Cancer.
    Börcsök J; Diossy M; Sztupinszki Z; Prosz A; Tisza V; Spisak S; Rusz O; Stormoen DR; Pappot H; Csabai I; Brunak S; Mouw KW; Szallasi Z
    Clin Cancer Res; 2021 Jul; 27(13):3734-3743. PubMed ID: 33947694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial Cancers in
    Smith ES; Da Cruz Paula A; Cadoo KA; Abu-Rustum NR; Pei X; Brown DN; Ferrando L; Sebastiao APM; Riaz N; Robson ME; Soslow RA; Reis-Filho JS; Mandelker D; Weigelt B
    JCO Precis Oncol; 2019; 3():. PubMed ID: 32914019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort.
    Leibowitz BD; Dougherty BV; Bell JSK; Kapilivsky J; Michuda J; Sedgewick AJ; Munson WA; Chandra TA; Dry JR; Beaubier N; Igartua C; Taxter T
    BMC Cancer; 2022 May; 22(1):587. PubMed ID: 35643464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel marker integrating multiple genetic alterations better predicts platinum sensitivity in ovarian cancer than HRD score.
    Yang F; Wei W; Li G; Lan Q; Liu X; Gao L; Zhang C; Fan J; Li J
    Front Genet; 2023; 14():1240068. PubMed ID: 37732324
    [No Abstract]   [Full Text] [Related]  

  • 11. Homologous Recombination Abnormalities Associated With
    Albitar M; Zhang H; Pecora A; Waintraub S; Graham D; Hellmann M; McNamara D; Charifa A; De Dios I; Ma W; Goy A
    Breast Cancer (Auckl); 2023; 17():11782234231198979. PubMed ID: 37789896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast Cancer.
    von Wahlde MK; Timms KM; Chagpar A; Wali VB; Jiang T; Bossuyt V; Saglam O; Reid J; Gutin A; Neff C; Lanchbury JS; Hatzis C; Hofstatter E; Pusztai L
    Clin Cancer Res; 2017 Mar; 23(5):1193-1199. PubMed ID: 27601588
    [No Abstract]   [Full Text] [Related]  

  • 13. Examining the prevalence of homologous recombination repair defects in ER+ breast cancers.
    Moore GM; Powell SN; Higginson DS; Khan AJ
    Breast Cancer Res Treat; 2022 Apr; 192(3):649-653. PubMed ID: 35092538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-cancer landscape of homologous recombination deficiency.
    Nguyen L; W M Martens J; Van Hoeck A; Cuppen E
    Nat Commun; 2020 Nov; 11(1):5584. PubMed ID: 33149131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer.
    Mutter RW; Riaz N; Ng CK; Delsite R; Piscuoglio S; Edelweiss M; Martelotto LG; Sakr RA; King TA; Giri DD; Drobnjak M; Brogi E; Bindra R; Bernheim G; Lim RS; Blecua P; Desrichard A; Higginson D; Towers R; Jiang R; Lee W; Weigelt B; Reis-Filho JS; Powell SN
    J Pathol; 2017 Jun; 242(2):165-177. PubMed ID: 28299801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversion of pathogenic
    Jo SY; Lee JD; Won J; Park J; Kweon T; Jo S; Sohn J; Kim SI; Kim S; Park HS
    iScience; 2024 Aug; 27(8):110469. PubMed ID: 39156639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level tumour methylation of
    Xu L; Liddell B; Nesic K; Geissler F; Ashwood LM; Wakefield MJ; Scott CL; Waddell N; Kondrashova O
    NAR Cancer; 2024 Sep; 6(3):zcae033. PubMed ID: 39055334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Synthetic Cytotoxicity of Combinatorial Chemoradiation Therapy in Homologous Recombination Deficient Tumors.
    Ma J; Shah R; Bell AC; McDermott N; Pei X; Selenica P; Haseltine J; Delsite R; Khan AJ; Lok BH; Ellis MJ; Aft RF; Setton J; Reis-Filho JS; Riaz N; Powell SN
    Int J Radiat Oncol Biol Phys; 2024 Jul; ():. PubMed ID: 38997095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 and RAD51C promotor methylation in human resectable pancreatic adenocarcinoma.
    Abdallah R; Zhao S; Garinet S; Hormigos K; Le Corre D; Cros J; Perez Toralla K; Bats AS; Augustin J; Bachet JB; Taly V; Blons H; Taieb J; Laurent-Puig P
    Clin Res Hepatol Gastroenterol; 2022 May; 46(5):101880. PubMed ID: 35151910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer.
    Wen H; Feng Z; Ma Y; Liu R; Ou Q; Guo Q; Shen Y; Wu X; Shao Y; Bao H; Wu X
    BMC Cancer; 2022 May; 22(1):550. PubMed ID: 35578198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.